Header cover image

U.K. (FTSE) Healthtech Industry Analysis

UpdatedJul 26, 2024
DataAggregated Company Financials
Companies8
  • 7D-4.0%
  • 3M6.6%
  • 1Y40.0%
  • YTDn/a

Over the last 7 days, the Healthtech industry has dropped 4.0%, driven by a pullback from Craneware of 2.0%. Over the past 12 months, the industry was up 40%. Earnings are forecast to grow by 29% annually.

Industry Valuation and Performance

Has the U.K. Healthtech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Jul 2024UK£898.1mUK£183.8m-UK£6,083,172.5262.1x-147.6x4.9x
Sun, 23 Jun 2024UK£873.6mUK£184.2m-UK£16,898,560.6860x-51.7x4.7x
Tue, 21 May 2024UK£836.4mUK£182.8m-UK£17,161,207.4857.4x-48.7x4.6x
Thu, 18 Apr 2024UK£861.6mUK£184.7m-UK£17,476,121.0857.3x-49.3x4.7x
Sat, 16 Mar 2024UK£882.4mUK£178.1m-UK£17,720,458.80107.5x-49.8x5x
Mon, 12 Feb 2024UK£828.4mUK£174.2m-UK£17,194,415.64101.9x-48.2x4.8x
Wed, 10 Jan 2024UK£2.1bUK£419.6m-UK£18,263,545.0059.8x-117.7x5.1x
Fri, 08 Dec 2023UK£2.1bUK£421.1m-UK£18,183,504.0059.8x-115.1x5x
Sun, 05 Nov 2023UK£2.1bUK£427.2m-UK£57,330,578.0056.8x-37.2x5x
Tue, 03 Oct 2023UK£2.1bUK£430.1m-UK£57,926,037.0057x-36.3x4.9x
Thu, 31 Aug 2023UK£2.1bUK£415.9m-UK£44,451,660.0040.2x-47.5x5.1x
Sat, 29 Jul 2023UK£1.7bUK£411.8m-UK£34,673,905.0029.9x-50.3x4.2x
Mon, 26 Jun 2023UK£1.7bUK£413.3m-UK£34,952,909.0030.7x-49.2x4.2x
Wed, 24 May 2023UK£1.7bUK£412.2m-UK£43,993,920.0051.9x-38.5x4.1x
Fri, 21 Apr 2023UK£1.8bUK£406.8m-UK£46,802,265.0063.9x-37.8x4.4x
Sun, 19 Mar 2023UK£2.0bUK£409.5m-UK£48,901,807.0070.2x-40.4x4.8x
Tue, 14 Feb 2023UK£2.1bUK£406.2m-UK£48,342,566.0073.9x-43.5x5.2x
Thu, 12 Jan 2023UK£2.2bUK£405.9m-UK£48,069,622.0082x-45.2x5.4x
Sat, 10 Dec 2022UK£2.2bUK£403.9m-UK£47,618,940.0087.5x-46.8x5.5x
Mon, 07 Nov 2022UK£2.2bUK£410.8m-UK£51,892,229.0078.6x-42.3x5.3x
Wed, 05 Oct 2022UK£2.2bUK£408.6m-UK£55,577,785.0075.4x-39x5.3x
Fri, 02 Sep 2022UK£2.1bUK£352.7m-UK£54,624,798.0077.4x-38.3x5.9x
Sun, 31 Jul 2022UK£2.2bUK£345.0m-UK£53,640,101.0091.2x-41.2x6.4x
Tue, 28 Jun 2022UK£2.3bUK£343.8m-UK£48,173,885.0085.2x-47.4x6.6x
Thu, 26 May 2022UK£1.7bUK£341.8m-UK£47,608,841.0076.1x-35.8x5x
Sat, 23 Apr 2022UK£2.0bUK£326.2m-UK£46,912,544.0098.8x-42.6x6.1x
Mon, 21 Mar 2022UK£1.9bUK£321.6m-UK£42,022,266.0084.1x-45.3x5.9x
Wed, 16 Feb 2022UK£2.1bUK£284.7m-UK£38,819,190.0081.6x-53.4x7.3x
Fri, 14 Jan 2022UK£2.5bUK£285.1m-UK£30,894,929.00102.6x-81.2x8.8x
Sun, 12 Dec 2021UK£2.6bUK£287.3m-UK£31,581,481.0097.7x-81.5x9x
Tue, 09 Nov 2021UK£2.8bUK£281.5m-UK£26,183,994.0098.1x-106.4x9.9x
Thu, 07 Oct 2021UK£2.8bUK£281.2m-UK£20,289,511.00101.3x-137.1x9.9x
Sat, 04 Sep 2021UK£3.0bUK£266.2m-UK£11,868,606.4868.9x-254.1x11.3x
Mon, 02 Aug 2021UK£3.0bUK£266.2m-UK£11,868,606.4861.9x-248.6x11.1x
Price to Earnings Ratio

-248.6x


Total Market Cap: UK£3.0bTotal Earnings: -UK£11,868,606.48Total Revenue: UK£266.2mTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Healthtech Industry Price to Earnings3Y Average -72.4x202220232024
Current Industry PE
  • Investors are pessimistic on the British Health Care Technology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 6.5x is higher than the industry's current PS ratio of 4.9x.
Past Earnings Growth
  • The earnings for companies in the Health Care Technology industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 12% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Comparison

How does U.K. Healthtech compare with similar industries?

GB Market-0.38%
Healthcare-0.41%
Healthtech-4.01%
Healthtech-4.01%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EMIS EMIS GroupUK£19.200.1%
+UK£16.1m
2.8%PE40.4x
INS InstemUK£8.300.3%
+UK£10.2m
23.9%PE59.8x
RENX RenalytixUK£0.143.8%
+UK£829.6k
-88.5%PS13x
COG Cambridge Cognition HoldingsUK£0.453.4%
+UK£624.5k
-53.8%PS1.4x
IQAI IQ-AIUK£0.01318.2%
+UK£443.4k
-55.2%PS4.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CRW

UK£24.00

Craneware

7D

-2.0%

1Y

61.3%

COG

UK£0.45

Cambridge Cognition Holdings

7D

3.4%

1Y

-53.8%

RENX

UK£0.14

Renalytix

7D

3.8%

1Y

-88.5%

IQAI

UK£0.013

IQ-AI

7D

18.2%

1Y

-55.2%

INS

UK£8.30

Instem

7D

0.3%

1Y

23.9%

EMIS

UK£19.20

EMIS Group

7D

0.1%

1Y

2.8%

PSY

UK£0.011

Shortwave Life Sciences

7D

-30.5%

1Y

-71.0%